Prolonged-release peptide containing the somatropin sequence

Our company has developed the recombinant growth hormone drug with prolonged action, which is achieved by fusion with an inert polypeptide. It contains repeating sequences added to increase the hydrodynamic volume and prolong the half-life of the drug from the blood plasma by slowing down renal filtration.

The use of a prolonged form of human growth hormone allows using the drug less often (once every 5−7 days) compared to its classic analogue (once a day).

Quick order and quote requests

Just complete the form below to quickly place an order or make a request for a custom quotation, or write to jualatisa@gmail.com